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ABSTRACT
Objectives: D-proline is an isomer of L-proline, naturally occurring amino acid. Apart from this, several proline homologs and analogs are available 
in nature. For instance, hydroxyproline one of proline analog plays a key role in collagen function. Inhibition of collagenase activity plays a significant 
role in protecting the unbalanced turnover of collagen, caused due to inflammation and photoaging of skin. This prompted us to carry out the study 
on proline and prolinamide isomers.
Methods: These proline and prolinamide isomers were evaluated on the docking behavior of bacterial collagenase using PatchDock. In addition, 
molecular physicochemical, drug-likeness, absorption, distribution, metabolism and excretion (ADME) analysis, synthesis, and characterization of 
four prolinamide isomers were also carried out.
Results: All the four synthesized prolinamide isomers showed >90% yield. The molecular physicochemical analysis revealed that proline and 
prolinamide isomers showed nil violation and complied well with the Lipinski’s rule of five. ADME analysis showed that prolinamide isomers 
predicated to have blood–brain barrier permeability. Docking studies revealed that D (S, R) prolinamide isomer showed the maximum atomic contact 
energy (−115.09 kcal/mol) with that of Clostridium histolyticum collagenase.
Conclusion: Thus, the present study showed the potential of proline and prolinamide isomers as collagenase inhibitors.
Keywords: Molecular docking, Proline, Prolinamide isomers, PatchDock, Clostridium histolyticum collagenase inhibitors.
INTRODUCTION
Proline is the α-pyrrolidine substituted amino acid of the protein. It 
is the only α-amino acid of protein which contains secondary amine. 
D-Proline is an isomer of the naturally occurring amino acid, L-Proline. 
D-Proline has been found in relatively high abundance in human plasma 
and saliva [1]. This amino acid might be of bacterial origin, but there 
is also evidence that this is endogenously produced through amino 
acid racemase activity [2]. L-Proline is one of the 20 amino acids used 
in living organisms as the building blocks of proteins. Proline is well 
known as a classical breaker of both the α-helical [3] and β-sheets 
structures in proteins and peptides, respectively. It is a non-essential 
amino acid that is synthesized from glutamic acid and other amino 
acids. It is an essential component of collagen and is important for the 
proper functioning of joints and tendons.
Several proline analogs and homologs occur in nature, for instance, trans-
3-hydroxyproline and trans-4-hydroxyproline shown as constituents of 
common proteins as a result of the post-translational process, especially 
in collagen. Similarly, 3- and 4- alkylated derivatives of proline and 
hydroxyproline as well as other proline analogs with ring restrictions 
(aziridine-2-carboxylic acid and azetidine-2-carboxylic acid) and ring 
expansions (pipecolic acid) are reported in natural products [4]. In 
cosmetic and personal care formulations, proline functions as a fragrance 
ingredient and as well as hair and skin conditioning agent [5]. Similarly, 
acyl proline salts functions as moisturizing agent [6] and N-Lauroyl 
proline as a slimming agent [7]. This prompted the present study to 
be carried out on proline and prolinamide isomers. These proline 
and prolinamide isomers were evaluated on the docking behavior of 
collagenase using PatchDock. In addition, molecular physicochemical, 
drug-likeness, and absorption, distribution, metabolism and excretion 
(ADME) analyses were also carried out.
MATERIALS AND METHODS
Materials
L-proline and D-proline (Loba), Boc anhydride (Avra), (R)-(+)-
Methylbenzylamine and (S)-(-)- methylbenzylamine (Aldrich), 
dicyclohexylcarbodiimide (DCC) (Avra), triethylamine (Avra), 
trifluoroacetic acid (Avra), and N,N’-dimethylaminopyridine (DMAP) 
are commercially available and used without any further purification.
Synthesis of prolinamide
To a stirred solution of triethylamine (5 mmol, 0.7 ml) in DCM was 
added Proline, 1a-b (4.35 mmol, 0.5 g) and boc anhydride (6.42 mmol, 
1.47 ml). The solution was stirred at room temperature for 1 h. The 
white cloudy liquid turned colorless. The organic phase was washed 
with (3 ml) saturated citric acid aqueous solution and (4 ml × 2) 
saturated NaCl aqueous solution and water. The organic phase was 
dried over Na2SO4, evaporated under vacuum to give 2a-b. [8] Under 
dry N2 atmosphere, DCC (1.1 mmol, 0.22 g), DMAP (0.3 mmol, 0.036 g), 
and 3a-b (0.8 mmol, 0.1 ml) were added to the stirred solution of 
2a-b (1 mmol, 0.21 g) dissolved in DCM (5 ml). The reaction mixture 
was stirred at room temperature for 48 h, and then the solvent was 
evaporated to half of the volume. The reaction mixture was quenched by 
the addition of dilute (0.5M) HCl and extracted with ethyl acetate. The 
organic phase was dried over Na2SO4. The crude was purified by column 
chromatography as 4a-d. To a stirred solution of 4a-d (1 mmol, 0.318 g) 
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dissolved in DCM (10 ml) was added trifluoroacetic acid (4.3 ml) at 
0°C. Slowly, the temperature was warmed to room temperature and 
stirring was continued for 5 h. [9] Then, the solvent was evaporated 
and neutralized with 10% NaOH aqueous solution. Ethyl acetate was 
added to extract the product. The organic phase was dried over Na2SO4. 
The crude was purified by column chromatography to get the product, 
5a-d as brown colored liquid. All the four prolinamide ligands were 
confirmed by 1H and nuclear magnetic resonance (13C NMR) analysis.
Ligand preparation for molecular docking
Chemical structures of ligands (L-Proline, D-Proline, D [S, R] prolinamide 
and L [S, R] prolinamide) were drawn in ChemBioDraw Ultra 12.0 and 
energy minimization of ligands was carried out by ChemBio three-
dimensional (3D) Ultra 12.0, according to the reported procedure [10]. 
These structures were employed for further PatchDock.
Target protein identification and preparation
The 3D structures of the Clostridium histolyticum collagenase (Protein 
Data Bank [PDB] ID: 4ARE with resolution of 2.19 A) were obtained 
from the Research Collaboratory for Structural Bioinformatics PDB 
(www.rcsb.org). A chain of the protein was processed individually by 
removing another chain, ligands in addition to the crystallographically 
observed water particles (water without hydrogen bonds). The protein 
mentioned above was prepared using UCSF Chimera software [11].
Molecular descriptors calculation
Molinspiration online database was used for the two selected ligands to 
calculate 13 descriptors (www.molinspiration.com) which are logP, polar 
surface area, molecular weight, number of atoms, number of O or N, number 
of OH or NH, number of rotatable bond, and drug-likeness including G 
protein-coupled receptors ligand, ion channel modulator, kinase inhibitor, 
nuclear receptor ligand, and number of violations to Lipinski’s rule [12].
ADME analysis
ADME analysis was performed by Swiss ADME analysis was carried by 
a standard default protocol [13].
Docking studies
Docking studies were carried out by the PatchDock online 
server (http://bioinfo3d.cs.tau.ac.il/PatchDock). PatchDock adopts 
geometry-based molecular docking algorithm method was used to 
recognize the binding scores, by binding residues atomic contact 
energy (ACE) of the given ligands. The docking results were obtained 
through the email address. We also use to get uniform resource 
locator which provides the top 20 solutions in a table form through 
email. From these, the top one solution (the docked protein-ligand 
complex) was selected and downloaded in a database (pdb) file 
format. Further, the binding site analysis was carried out by PyMOL 
software [14].
RESULTS AND DISCUSSION
In the present study, proline (L-Proline, D-Proline) and prolinamide 
(D [S, R] prolinamide and L [S, R] prolinamide) isomers have been 
synthesis and selected to evaluate as bacterial collagenase inhibitory 
activity using in silico method. All the four prolinamide isomers 
(Scheme 1; 5a-5d) were confirmed by Proton (1H) and Carbon (13C) 
NMR analysis and results were shown below.
LR-prolinamide (5a)
Yield: 97%;1H NMR: (400 MHz, CDCl3) δ (ppm): 8.13 (1H, d, J = 16 Hz), 
7.22 (5H, s), 5.04–4.89 (1H, m), 3.87–3.78 (1H, m), 3.01–2.82 (2H, m), 
2.14–1.99 (1H, m), 1.85–1.56 (4H, m), 1.34 (3H, d, J = 12 Hz);13C NMR: 
(100 MHz, CDCl3) δ (ppm): 172.6, 143.5, 128.3, 126.0, 125.7, 60.1, 48.2, 
46.8, 30.4, 25.5, 22.1.
LS-prolinamide (5b)
Yield: 93%;1H NMR: (400 MHz, CDCl3) δ (ppm): 8.72 (1H, d, 
J = 7.2 Hz), 7.23–7.13 (5H, m), 4.84–4.81 (1H, m), 4.52 (1H, t, J = 8 Hz), 
3.15–3.10 (2H, m), 2.30–2.26 (1H, m), 1.83–1.68 (4H, m), 1.34 (3H, d, 
J = 8 Hz);13C NMR: (100 MHz, CDCl3) δ (ppm): 167.9, 143.4, 128.6, 127.2, 
125.6, 59.5, 50.2, 46.3, 30.0, 24.4, 22.0.
DR-prolinamide (5c)
Yield: 91%;1H NMR: (400 MHz, CDCl3) δ (ppm): 8.69 (1H, d, 
J = 8 Hz), 7.22–7.14 (5H, m), 4.86–4.82 (1H, m), 4.50 (1H, t, J = 8 Hz), 
3.16–3.12 (2H, m), 2.29 (1H, d, J = 8 Hz), 1.82–1.75 (4H, m), 1.35 (3H, d, 
J = 8 Hz);13C NMR: (100 MHz, CDCl3) δ (ppm): 168.1, 143.4, 128.6, 127.2, 
125.6, 59.5, 50.1, 46.3, 30.1, 24.4, 22.1.
Scheme 1: Synthesis of prolinamide isomers
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DS-prolinamide (5d)
Yield: 95%; 1H NMR: (400 MHz, CDCl3) δ (ppm): 8.39 (1H, d, J = 16 Hz), 
7.29 (5H, s), 5.00 (1H, t, J = 16 Hz), 4.56 (2H, s), 4.07–4.00 (1H, m), 
3.07–2.96 (1H, m), 2.31–2.15 (1H, m), 1.89–1.70 (3H, m), 1.47 (3H, d, 
J = 12 Hz);13C NMR: (100 MHz, CDCl3) δ (ppm): 171.7, 143.5, 128.4, 
126.0, 125.9, 60.1, 48.6, 46.8, 30.5, 25.3, 22.2.
The molecular formula of Proline is C5H9NO2. The International 
Nomenclature of Cosmetic Ingredients name is proline. Proline 
is an amino acid containing pyrrole type nitrogen. The unique 
cyclic structure of proline (side chain) gives proline an exceptional 
conformational rigidity compared to other amino acids. It is one 
of the two amino acids (along with glycine) that do not follow the 
typical Ramachandran plot. Proline is used in skin care and hair 
care products and cleansers [5]. Similarly, proline analogs and 
homologs have reported to possess cosmetic applications [6,7]. 
Matrix metalloproteinases (MMPs) plays a key role in the various 
physiological process (angiogenesis, wound healing) and pathological 
process (photo-aging [15], inflammation, and metastasis). Therefore, 
design and development of MMP inhibitors have promoted significant 
interest among the scientist [16].
It could be beneficial to know the physiochemical, drug-likeness and 
ADME properties of proline and prolinamide isomers before carry out 
docking studies. The molecular physicochemical analysis revealed that 
proline and prolinamide isomers showed nil violation and complied 
well with the Lipinski’s rule of five (as shown in Table 1).
With regard to drug-likeness score, if the score >0 is active, −5.0–−0.0 
is moderate active, and <−5.0 is inactive [17]. The ligands (prolinamide 
isomers) showed active score toward two descriptions (ion channel 
modulator and protease inhibitor). Interestingly, none of them showed 
inactive score as shown in Table 2.
ADME analysis showed that all the ligands (except L-proline) predicated 
to have blood–brain barrier permeability effect (Table 3).
The anti-collagenase activity of several natural/synthetic products has 
been evaluated using C. histolyticum collagenase as biomarker, and its 
inhibitors have been developed for treating bacterial corneal keratitis 
disease [11]. Present docking studies revealed that D (S, R) prolinamide 
isomer showed the maximum ACE (−115.09 kcal/mol) with that 
of C. histolyticum collagenase (as shown in Table 4), while L (S, R) 
prolinamide isomer showed poor binding phenomenon as reported by 
Akdogan et al. [18].
Table 1: Molecular physicochemical descriptors analysis of proline and prolinamide isomers using Molinspiration online software tool
Ligand names Log Aa TPSAb Natomsc MWd nONe nOHNHf Nviolationsg Nrotbh Volumei
LS 1.55 41.12 16 218.30 3 2 0 3 217.61
LR 1.55 41.12 16 218.30 3 2 0 3 217.61
DS 1.55 41.12 16 218.30 3 2 0 3 217.61
DR 1.55 41.12 16 218.30 3 2 0 3 217.61
L-proline −1.72 49.33 8 115.13 3 2 0 1 108.43
D-proline −1.72 49.33 8 115.13 3 2 0 1 108.43
Where LS: L-prolinamide (S), LR: L-prolinamide (R), DS: D-prolinamide (S), DR: D-prolinamide (R). aOctanol-water partition coefficient, bPolar surface area, cNumber of 
non-hydrogen atoms, dMolecular weight, eNumber of hydrogen bond acceptors (O and N atoms), fNumber of hydrogen bond donors (OH and NH groups), gNumber of 
rule of 5 violations, hNumber of rotatable bonds, iMolecular volume















LS −0.01 0.16 −0.39 −0.82 0.21 −0.10
LR −0.01 0.16 −0.39 −0.82 0.21 −0.10
DS −0.01 0.16 −0.39 −0.82 0.21 −0.10
DR −0.01 0.16 −0.39 −0.82 0.21 −0.10
L-proline −2.15 −1.54 −3.08 −3.07 −1.72 −1.85
D-proline −2.15 −1.54 −3.08 −3.07 −1.72 −1.85
*GPCR: G protein-coupled receptors. Where LS: L-prolinamide (S), LR: L-prolinamide (R), DS: D-prolinamide (S), DR: D-prolinamide (R)
Table 3: ADME analysis of proline and prolinamide isomers using Swiss ADME online software tool
Ligand names GI● BBB# P-gp□ CYP1A2* CYP2C19* CYP2C9* CYP2D6* CYP3A4* Log Kp◊
LS High Yes No No No No No No −7.26
LR High Yes No No No No No No −7.26
DS High Yes No No No No No No −7.26
DR High Yes No No No No No No −7.26
L-proline High No No No No No No No −8.78
D-proline High Yes No No No No No No −8.78
●Gastrointestinal absorption, #blood–brain barrier permanent, □P-gp: P-glycoprotein substrate, *CYP: Cytochrome P450 inhibitors, ◊Skin permeation (cm/s). Where 
LS: L-prolinamide (S), LR: L-prolinamide (R), DS: D-prolinamide (S), DR: D-prolinamide (R). ADME: Absorption, distribution, metabolism, and excretion
Table 4: The interaction energy analysis of proline and 








LS +24.10 Gln 710 3.51
LR +24.10 Gln 710 3.51
DS 115.09 Asn 210 2.87
DR 115.09 Asn 210 2.87
L-proline 43.04 Tyr 528 Thr 421 1.7 and 2.9 2.4
D-proline 69.14 Tyr 724 2.5
◊ atomic contact energy, where LS: L-prolinamide (S), LR: L-prolinamide (R), 
DS: D-prolinamide (S), DR: D-prolinamide (R), C. histolyticum: Clostridium 
histolyticum
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The present finding was in good agreement with the earlier 
report, where author’s developed pyrrolidine scaffold based MMP 
inhibitors [19]. In the present study, interaction with Asn 210 amino 
acid residue has been shown by D (S, R) prolinamide isomer (Table 4). 
The present finding was in good agreement with an earlier report [11].
CONCLUSION
In the present study, D (S, R) prolinamide isomer and D-proline 
exhibited high ACE value, when compared to L (S, R) prolinamide 
isomer and L-proline. Thus, the present study showed the potential of 
proline (Pyrrolidine 2-carboxylic acid) and prolinamide (Pyrrolidine 
2-carboxylic acid amide) isomers as bacterial collagenase inhibitors.
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